effect of Omega 3 on UTI
Phase 3
Recruiting
- Conditions
- rinary tract infection.Urinary tract infection, site not specifiedN39.0
- Registration Number
- IRCT20191104045328N22
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Children 4-18 years old with urinary tract infection
Consent to participate in the study
Exclusion Criteria
The presence of underlying kidney and liver disease
Sensitivity to omega-3
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fever. Timepoint: The beginning and end of treatment. Method of measurement: Mercury Therommeter.;Dysuria. Timepoint: The beginning and end of treatment. Method of measurement: Take a history.;Frequency. Timepoint: The beginning and end of treatment. Method of measurement: Take a history.;Abdominal pain. Timepoint: The beginning and end of treatment. Method of measurement: Take a history.;Urinary incontinence. Timepoint: The beginning and end of treatment. Method of measurement: Take a history.
- Secondary Outcome Measures
Name Time Method